This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Kunihiko Nakai: Innovator in Hemoglobin Complexes
Introduction
Kunihiko Nakai is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of innovative hemoglobin complexes. His work focuses on enhancing the properties of hemoglobin through novel chemical modifications.
Latest Patents
Nakai holds a patent for a "Nitric monoxide metabolite-polyoxyalkylene-hemoglobin complex." This invention discloses a complex with a molecular weight ranging from 100,000 to 2,000,000 daltons. In this complex, a polyoxyalkylene derivative is bound to 10 to 30% of the total bindable amino groups in hemoglobin. Additionally, a nitric monoxide metabolite is bound to 10 to 100% of the total thiol groups of cysteine residues. This innovative approach has potential applications in various medical and therapeutic fields.
Career Highlights
Throughout his career, Nakai has demonstrated a commitment to advancing scientific knowledge and practical applications in biochemistry. His research has led to the development of unique compounds that could improve oxygen delivery and utilization in biological systems. His work is recognized for its potential impact on medical treatments and therapies.
Collaborations
Nakai has collaborated with esteemed colleagues, including Ichiro Sakuma and Akira Kitabatake. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biochemistry.
Conclusion
Kunihiko Nakai's contributions to the field of hemoglobin complexes highlight his innovative spirit and dedication to scientific advancement. His patent on the nitric monoxide metabolite-polyoxyalkylene-hemoglobin complex represents a significant step forward in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile